HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 72 filers reported holding HARVARD BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $104,706 | +1208.8% | 37,800 | +3189.8% | 0.00% | – |
Q1 2021 | $8,000 | -68.0% | 1,149 | -80.8% | 0.00% | – |
Q4 2020 | $25,000 | +316.7% | 5,988 | +236.6% | 0.00% | – |
Q3 2020 | $6,000 | -45.5% | 1,779 | -41.9% | 0.00% | – |
Q2 2020 | $11,000 | – | 3,061 | +5786.5% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 52 | -99.8% | 0.00% | – |
Q1 2019 | $96,000 | +33.3% | 22,163 | -2.3% | 0.00% | – |
Q4 2018 | $72,000 | -38.5% | 22,678 | +1.2% | 0.00% | – |
Q3 2018 | $117,000 | -1.7% | 22,409 | -0.0% | 0.00% | – |
Q2 2018 | $119,000 | +8.2% | 22,412 | +1.1% | 0.00% | – |
Q1 2018 | $110,000 | -89.7% | 22,162 | -92.1% | 0.00% | -100.0% |
Q3 2015 | $1,065,000 | -71.8% | 281,878 | -57.4% | 0.00% | -75.0% |
Q2 2015 | $3,771,000 | -9.0% | 661,513 | -7.1% | 0.00% | -20.0% |
Q1 2015 | $4,144,000 | -28.1% | 711,988 | -30.0% | 0.01% | -28.6% |
Q4 2014 | $5,764,000 | +40.7% | 1,016,628 | +1.5% | 0.01% | +40.0% |
Q3 2014 | $4,097,000 | +9.0% | 1,001,830 | +21.3% | 0.01% | +25.0% |
Q2 2014 | $3,757,000 | – | 825,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |